Morepen Labs receives 'Adequate' ESG rating from CRISIL
Morepen Laboratories Limited received an 'Adequate' ESG rating of 'CRISIL ESG 60' from Crisil ESG Ratings & Analytics. The rating was assigned independently by CRISIL based on publicly available information for fiscal year 2026.
The ESG rating was assigned independently by CRISIL based on publicly available information and is categorized as 'Adequate'. This does not represent a significant change or event that would materially impact the company's operations or stock.
The company received an ESG rating that is neither significantly positive nor negative, and it was assigned independently without the company's engagement, making the impact neutral.
Morepen Laboratories Limited has received an intimation on September 21, 2026, at 7:55 p.m. (IST) that Crisil ESG Ratings & Analytics Limited has assigned an overall ESG rating of ‘CRISIL ESG 60’ to the company, indicating an ‘Adequate’ rating category.
It is noted that Morepen Laboratories Limited had not engaged CRISIL for these ESG ratings. CRISIL independently assigned the ESG Rating based on publicly disclosed information for the fiscal year 2026, which is available on CRISIL's website.
This ESG rating is for informational purposes and records.
What to do with a filing like this
Morepen Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under esg reports. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Morepen Laboratories Limited. Read the original for the full detail.